Molecular Regenerative therapy for DM: EGF increases insulin-secreting cell mass and function via up regulation of its target genes, 19/September/2014, 09.07 am

Therapeutic insights into the treatment of metabolic diseases, cardiac disorders, ageing and longevity: Fisetin, a Flavonoid enriched in strawberries, suppresses the expression of tumor suppressor p53 via up regulation of its target gene, 19/September/2014, 8.37 am
September 19, 2014
AntagomiR-based Regenerative stem cell therapy for Myocardial Infarction: MiRNA-134 inhibits myocardial function after myocardial infarction via down regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 19/September/2014, 12.30 pm
September 19, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Molecular Regenerative therapy for DM: EGF increases insulin-secreting cell mass and function via up regulation of its target genes, 19/September/2014, 09.13 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance:  It is known for years that EGF signalling promotes insulin sensitivity. However, mechanistic basis of this is far from clear.  This study suggests, for the first time, that  EGF, by increasing the expression of its target gene, it may increase insulin-secreting cell mass. Thereby, it may increase the insulin sensitivity.  Thus, pharmacological formulations encompassing “EGF or its activator”  may be used to treat DM.

Comments are closed.